Organisations › Biological

Cepheid

Sunnyvale, CA, United StatesFounded 1996Industry

Cepheid makes molecular diagnostic systems including an anthrax test. CBRNE-relevant work is a notable product line according to its website. It is headquartered in Sunnyvale, CA, United States.

What it does

PCR/molecular diagnosticsPCRanthrax test

Threats covered

anthraxEbola/filoviruses
Categories

Profile

Cepheid is a Sunnyvale, California molecular diagnostics company, founded in 1996, known for its GeneXpert automated PCR systems and tests. Danaher agreed to acquire it on 6 September 2016 for 53 dollars a share, about 4 billion dollars, and completed the transaction on 4 November 2016, making it a wholly owned Danaher subsidiary.

More profile

In biodefense it developed an anthrax detection test with Northrop Grumman for the US Postal Service in 2004, and its Xpert Ebola test received a US Food and Drug Administration emergency use authorisation and World Health Organization procurement eligibility in 2015. A government partnership page describes molecular solutions offered to government customers.

Biodefense is a small part of a mainly clinical diagnostics business.

Ownership

Wholly owned subsidiary of Danaher Corporation since 4 November 2016 (about 4 billion dollar acquisition)

Parent: Danaher (acquired Nov 2016) (checked)

Sources (5)
Not verified or not found
  • A 2026 WHO emergency-use listing for a haemorrhagic fever panel appeared in one search summary and was not opened.
  • Government contract values: not read.
Questions

What does Cepheid do?

Cepheid makes molecular diagnostic systems including an anthrax test. CBRNE-relevant work is a notable product line according to its website.

Where is Cepheid based?

HQ (as found): Sunnyvale, CA. HQ country: US.

Who owns Cepheid?

Wholly owned subsidiary of Danaher Corporation since 4 November 2016 (about 4 billion dollar acquisition). Parent: Danaher (acquired Nov 2016) (checked)

Profiles are compiled from public sources and sampled-checked, not fully audited. Last verified 17 October 2026. Report a correction